Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jay

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Drug Delivery and Translational Research|January 29, 2025
Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeuticsParnian Mehinrad, Ahmed Abdelfattah, Sams M A Sadat, et al.
Journal of General Internal Medicine|October 20, 2025
Impact of Substance Use Navigators on Initiation of Treatment for Substance Use Disorders and 30-Day Unplanned ReadmissionArianna Campbell, Allison D Rosen, Steven J Shoptaw, et al.
Chemical Biology & Drug Design|January 1, 2020
Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein-protein interactionFrancesco Gentile, Ahmed H Elmenoufy, Gloria Ciniero, et al.
Pharmaceutics|December 23, 2022
Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation ResponseNolan Jackson, Abdulaziz Alhussan, Kyle Bromma, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 26, 2011
Piroxicam and meloxicam ameliorate hepatic oxidative stress and protein carbonylation in Kupffer and sinusoidal endothelial cells promoted by ischemia-reperfusion injuryEduardo E Montalvo-Javé, José A Ortega-Salgado, Andrés Castell, et al.
European Journal of Medicinal Chemistry|August 2, 2020
Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathwayAhmed H Elmenoufy, Francesco Gentile, David Jay, et al.
Journal of Medicinal Chemistry|August 2, 2019
Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPFAhmed H Elmenoufy, Francesco Gentile, David Jay, et al.
Frontiers in Oncology|April 4, 2022
Modulation of ERCC1-XPF Heterodimerization Inhibition <i>via</i> Structural Modification of Small Molecule Inhibitor Side-ChainsClaudia Weilbeer, David Jay, James C Donnelly, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 8, 2025
The present and future of cardiological telemonitoring in Europe: a statement from seven European countriesThomas M Helms, Giuseppe Boriani, Hans-Peter Brunner-La Rocca, et al.
European Heart Journal|June 3, 2017
Remote management of heart failure using implantable electronic devicesJohn M Morgan, Sue Kitt, Jas Gill, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Drug Delivery and Translational Research|January 29, 2025
Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeuticsParnian Mehinrad, Ahmed Abdelfattah, Sams M A Sadat, et al.
Journal of General Internal Medicine|October 20, 2025
Impact of Substance Use Navigators on Initiation of Treatment for Substance Use Disorders and 30-Day Unplanned ReadmissionArianna Campbell, Allison D Rosen, Steven J Shoptaw, et al.
Chemical Biology & Drug Design|January 1, 2020
Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein-protein interactionFrancesco Gentile, Ahmed H Elmenoufy, Gloria Ciniero, et al.
Pharmaceutics|December 23, 2022
Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation ResponseNolan Jackson, Abdulaziz Alhussan, Kyle Bromma, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 26, 2011
Piroxicam and meloxicam ameliorate hepatic oxidative stress and protein carbonylation in Kupffer and sinusoidal endothelial cells promoted by ischemia-reperfusion injuryEduardo E Montalvo-Javé, José A Ortega-Salgado, Andrés Castell, et al.
European Journal of Medicinal Chemistry|August 2, 2020
Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathwayAhmed H Elmenoufy, Francesco Gentile, David Jay, et al.
Journal of Medicinal Chemistry|August 2, 2019
Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPFAhmed H Elmenoufy, Francesco Gentile, David Jay, et al.
Frontiers in Oncology|April 4, 2022
Modulation of ERCC1-XPF Heterodimerization Inhibition <i>via</i> Structural Modification of Small Molecule Inhibitor Side-ChainsClaudia Weilbeer, David Jay, James C Donnelly, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 8, 2025
The present and future of cardiological telemonitoring in Europe: a statement from seven European countriesThomas M Helms, Giuseppe Boriani, Hans-Peter Brunner-La Rocca, et al.
European Heart Journal|June 3, 2017
Remote management of heart failure using implantable electronic devicesJohn M Morgan, Sue Kitt, Jas Gill, et al.
Pageof 4